Pricing Log in Create free account

Contineum Therapeutics, Inc. (CTNM) vs Nautilus Biotechnology, Inc. (NAUT)

Contineum Therapeutics, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Contineum Therapeutics, Inc. and Nautilus Biotechnology, Inc. are of similar size ($297.2M and $274.9M). Across the 9 metrics below, Nautilus Biotechnology, Inc. leads on 5 and Contineum Therapeutics, Inc. on 4.

Valuation

Metric CTNM NAUT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.10 2.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (24.64%) (21.84%) (33.15%)
Free cash flow yield (20.33%) (19.80%) (25.50%)

Profitability

Metric CTNM NAUT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (28.01%) (36.21%) (56.36%)
Return on assets (26.57%) (30.00%) (48.04%)
Return on invested capital (1,334.41%) (83.32%) 0.00%

Growth

Metric CTNM NAUT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 0.46% 16.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTNM NAUT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 37.17 10.14 4.72
Net debt to EBITDA 3.88 1.67 0.96

Dividend

Metric CTNM NAUT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CTNM NAUT Biotechnology median
Market cap 297.21m 274.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack